I was troubled by the false choice presented in a recent opinion column from Sabrina Walker. Patients do not need to choose between lowering drug prices and protecting pharmaceutical innovation. The drug pricing reforms that are under consideration by the U.S. Senate will maintain the innovation we need at prices we can afford. Like Sabrina, […]
